Fifth Third Bancorp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
|
|||||
|
2025
Q1 | $117K | Buy |
|
|||||
|
2024
Q4 | $109K | Sell |
|
|||||
|
2024
Q3 | $92.6K | Buy |
|
|||||
|
2024
Q2 | $98.6K | Buy |
|
|||||
|
2024
Q1 | $86.1K | Buy |
|
|||||
|
2023
Q4 | $78K | Sell |
|
|||||
|
2023
Q3 | $70K | Buy |
|
|||||
|
2023
Q2 | $38.8K | Buy |
|
|||||
|
2023
Q1 | $35.3K | Buy |
|
|||||
|
2022
Q4 | $36K | Sell |
|
|||||
|
2022
Q3 | $34K | Sell |
|
|||||
|
2022
Q2 | $41K | Buy |
|
|||||
|
2022
Q1 | $30K | Buy |
|
|||||
|
2021
Q4 | $21K | Hold |
|
|||||
|
2021
Q3 | $24K | Buy |
|
|||||
|
2021
Q2 | $1K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $9K | Sell |
|
|||||
|
2019
Q4 | $13K | Buy |
|
|||||
|
2019
Q3 | $9K | Sell |
|
|||||
|
2019
Q2 | $84K | Hold |
|
|||||
|
2019
Q1 | $88K | Buy |
|
|||||
|
2018
Q4 | $0 | Sell |
|
|||||
|
2018
Q3 | $11K | Sell |
|
|||||
|
2018
Q2 | $16K | Hold |
|
|||||
|
2018
Q1 | $14K | Sell |
|
|||||
|
2017
Q4 | $27K | Sell |
|
|||||
|
2017
Q3 | $45K | Sell |
|
|||||
|
2017
Q2 | $44K | Buy |
|
|||||
|
2017
Q1 | $39K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $25K | Sell |
|
|||||
|
2016
Q2 | $182K | Sell |
|
|||||
|
2016
Q1 | $199K | Sell |
|
|||||
|
2015
Q4 | $287K | Buy |
|
|||||
|
2015
Q3 | $48K | Sell |
|
|||||
|
2015
Q2 | $122K | Sell |
|
|||||
|
2015
Q1 | $105K | Buy |
|